MedicGo
Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments. Preliminary results.
Metadata
JournalRev Inst Hyg Mines (Hasselt)Not FoundDate
1979
Type
Research Support, Non-U.S. Gov't
Journal Article
Trial
Comparative Study
Trial
Volume
1979 / 34 : 115-23
Author
Minette A , Marcq M
Doi
Not Found
PMIDMESH
Adrenergic beta-Agonists
Adult
Asthma
Blood Pressure
Bronchitis
Bronchodilator Agents
Fenoterol
Forced Expiratory Volume
Humans
Ipratropium
Male
Placebos
Scopolamine Derivatives
Time Factors
Abstract
The changes in FEV1 and in specific conductance induced by 200 micrograms oxitropium bromide given as pressurized aerosol were measured at 8 time intervals during 7 hours after inhalation in a group of 19 patients with reversible broncho-obstruction. The working of the drug was compared to the functional values observed at the same time intervals after placebo, 40 micrograms ipratropium bromide and 400 micrograms fenoterol. Both oxitropium and ipratropium were definitely and significantly superior to placebo at all time intervals. Oxitropium was superior to ipratropium at the 7th hour. At this time interval the difference was significant At the 7th hour oxitropium gave higher mean results than fenoterol, but this difference was not significant. The drug was also compared to its competitors regarding its subjective and cardiovascular tolerance. No unfavourable side-effects were observed.
Fav
Like
Download
Share
Export
Cite
R
Rev Inst Hyg Mines (Hasselt)Revue de l'Institut d'hygiene des mines
Metadata
Location
From

No Data

© 2017 - 2020 Medicgo
Powered by some medical students